Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023
Net Sales ₹30 Cr₹26 Cr₹26 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹30 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹30 Cr
Mar2024₹26 Cr
Mar2023₹26 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2025 ₹30 Cr
19.16
Mar2024 ₹26 Cr
0.00
Mar2023 ₹26 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹68.7 Cr 6.9% -2.4% -52.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,650.5 Cr 3.7% 3.1% -3.7% Stock Analytics
KIRI INDUSTRIES ₹2,816.9 Cr -3.8% -5.5% -16.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,581.8 Cr -0.9% -5.2% -35.5% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,142.8 Cr 1.1% 4.6% 28.4% Stock Analytics
BODAL CHEMICALS ₹646.0 Cr -0.7% 2.9% -17.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

6.9%

-2.4%

-52.3%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses